Prospective open label non-comparative study of the safety, efficacy and tolerability of high dose ritonavir/lopinavir [lopinavir/ritonavir; Kaletra] liquid in salvage therapy for PI [protease inhibitor] resistant HIV & a PK [pharmacokinetic] equivalence sub-study of high dose ritonavir/lopinavir capsules
Latest Information Update: 17 Sep 2021
Price :
$35 *
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 23 Nov 2005 New trial record.